Therapeutic efficacy of INX-315, a selective CDK2 inhibitor, in solid tumors [OVCAR3 RNAseq]

ABSTRACT: We performed RNA sequencing on OVCAR3 parental cells treated with either control vehicle for 4 days or 300 nM INX-315 for 7 days.

ORGANISM(S): Homo sapiens

PROVIDER: GSE243152 | GEO | 2023/11/22

REPOSITORIES: GEO